Company
ForteBio
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
ForteBio was recently acquired by Pall Corporation for $159 million. ForteBio developed and marketed a new biotech research instrument for the rapid measurement of molecular binding useful in biopharmaceutical R&D.
Loading relationship preview